NIH
|
Gout treatment may help prevent obesity-related type 2 diabetes, suggests small NIH study |
The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health. Their study appears in Diabetes, Endocrinology, and Metabolism. |
NIH
|
This National Diabetes Month, care for your health after gestational diabetes |
Up to one in every 10 pregnancies in the United States is affected by gestational diabetes, a type of diabetes found for the first time when a woman is pregnant. |
NIH
|
Gene mutation points to new way to fight diabetes, obesity, heart disease |
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. |
NIH
|
Gastric banding as effective as metformin in slowing progression of prediabetes, type 2 diabetes |
Half of BetaFat study participants underwent a gastric banding procedure, which narrows the upper part of the stomach to slow digestion. |
NIH
|
New NIH reference book is one-stop resource for diabetes medical information |
Covering the spectrum of diabetes, the book describes data and trends in the United States, complications of diabetes and related conditions, and prevention and medical care, including outlining major diabetes research findings. |
NIH
|
Diabetes in America, 3rd Edition |
Diabetes in America, 3rd Edition, is a compilation and assessment of epidemiologic, public health, clinical, and clinical trial data on diabetes and its complications in the United States. |
NIH
|
Two diabetes medications don’t slow progression of type 2 diabetes in youth |
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body’s ability to make insulin, according to results published online June 25 in Diabetes Care. |
NIH
|
Islet transplantation improves quality of life for people with hard-to-control type 1 diabetes |
Quality of life for people with type 1 diabetes who had frequent severe hypoglycemia — a potentially fatal low blood glucose (blood sugar) level — improved consistently and dramatically following transplantation of insulin-producing pancreatic islets, according to findings published online March 21 in Diabetes Care. |
|
Insulin Resistance Pioneer Gerald Reaven Dies |
Gerald (Jerry) Reaven, who made fundamental contributions to the study of insulin resistance, died last week (February 12). The longtime professor at Stanford University School of Medicine researched the role of insulin in diabetes, hypertension, and a plethora of other diseases. |
NIH
|
Does infant formula affect development of type 1 diabetes? |
Feeding infants who are at risk for type 1 diabetes a formula with proteins that have been broken down didn’t affect their chance of developing the disease. The results disprove a hypothesis and suggest no change in current guidelines for type 1 diabetes prevention. |
NIH
|
Factors contributing to higher incidence of diabetes for black Americans |
A study found that biological risk factors—including weight and fat around the abdomen—are primarily responsible for higher rates of diabetes for black Americans compared with white Americans.
The study suggests that making positive changes in known risk factors, like losing excess weight, can help reduce the racial health disparity f or developing diabetes. |
NIH
|
Examining the effects of weight gain and loss—multiple molecules at a time |
In a controlled study of weight gain and loss, researchers have assembled a comprehensive molecular profile of dramatic changes that occur in humans during short periods of weight fluctuation. |